University College London (UCL) spin-out Abcodia has raised £5.25m ($8.1m) in a venture round which will be used to bring the UK-based medtech’s early detection cancer test to the US.
Venture firm Scottish Equity Partners co-led the round along with Cambridge University’s university venturing fund Cambridge Innovation Capital, joined in participation by Albion Ventures and UCL Business, the technology transfer unit of UCL. The round brings the total invested in Abcodia to $10.2m.
The company, launched in 2010, is commercialising…
